Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2021 - $105,177; 2020 - $104,174; allowance for credit losses: 2021 - $19; 2020 - $13)	$ 118,746	$ 123,044
Trading securities	4,482	4,501
Equity securities	318	129
Mortgage loans on real estate, net of allowance for credit losses (portion at fair value: 2021 - $739; 2020 - $832)	17,991	16,763
Policy loans	2,364	2,426
Derivative investments	5,437	3,109
Other investments	4,292	3,984
Total investments	153,630	153,956
Cash and invested cash	2,612	1,708
Deferred acquisition costs and value of business acquired	6,081	5,812
Premiums and fees receivable	580	486
Accrued investment income	1,189	1,257
Reinsurance recoverables, net of allowance for credit losses	20,295	16,496
Funds withheld reinsurance assets	517	530
Goodwill	1,778	1,778
Other assets	18,036	15,960
Separate account assets	182,583	167,965
Total assets	387,301	365,948
Liabilities
Future contract benefits	41,030	40,814
Other contract holder funds	111,702	105,405
Short-term debt	300
Long-term debt	6,325	6,682
Reinsurance related embedded derivatives	206	392
Funds withheld reinsurance liabilities	2,118	1,946
Payables for collateral on investments	8,946	6,222
Other liabilities	13,819	13,823
Separate account liabilities	182,583	167,965
Total liabilities	367,029	343,249
Contingencies and Commitments (See Note 13)
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized
Common stock – 800,000,000 shares authorized; 177,193,515 and 192,329,691 shares issued and outstanding as of December 31, 2021, and December 31, 2020, respectively	4,735	5,082
Retained earnings	9,096	8,686
Accumulated other comprehensive income (loss)	6,441	8,931
Total stockholders' equity	20,272	22,699
Total liabilities and stockholders' equity	$ 387,301	$ 365,948